Clinical Trial

Artificial Intelligence for Highly Myopic Cataract

Study acronym: AI-HMC
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-25; most recent amendment 2026-05-06.
Trial Details
NCT Number NCT06616506
Lead Sponsor Shanghai High Myopia Study Group
Collaborators: Eye and ENT Hospital of Fudan University
Conditions Cataract, High Myopia, Myopia, Automatic Judgement, Risk Reduction, Diagnoses Disease
Enrollment 500,000 participants
Start Date 2016-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-11